NOUREX
Live / Allowed — Fifth extension granted (statement of use) (as of 03 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 14 Feb 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 97794497
- Mark type
- Word mark
- Filed
- 14 Feb 2023
- Published for opposition
- 23 Jan 2024
- Attorney of record
- Wisu Sul
Goods and services
- Class 005 — Pharmaceuticals: Veterinary preparations, namely, vaccines, oral and injectable antimicrobial preparations for the treatment and control of infectious diseases in food producing animals and livestock, immunorestorative biopharmaceuticals, and other medicinal drugs for the prevention and treatment of viral, infectious, and metabolic diseases in animals; medicated animal feed and water additives in the nature of dietary supplements for production enhancement for livestock; veterinary preparations for controlling and destroying vermin, namely, ectoparasiticides, insecticides and parasiticides; Veterinary hormone preparations and hormone preparation implants for animals, namely, progesterone, estrogen and testosterone; Veterinary preparations for food safety, food animal processing and food animal processing aids, namely, bacteriophage, antimicrobials and vaccines to reduce levels of food borne pathogens carried in or on livestock, poultry or meat and to inhibit microbial decomposition in food and animal feed; veterinary preparations, namely, medical diagnostic agents, tests, and preparations and substances to identify pathogens and residues of biological interest for veterinary use; Veterinary preparations for companion animals, namely, to treat parasitic infections, diabetes, endocrine disorders, obesity, blood disorders, dental and oral diseases, pain, inflammation, gastrointestinal disorders, central nervous system disorders, neurological and neurodegenerative disorders, cardiovascular conditions, dermatologic conditions, urogenital and urinary conditions, osteoarthritis, otitis, wound healing, infections, allergy atopic conditions, liver diseases and disorders and nonsurgical sterilization, namely, hormones for the control/prevention of reproductive functions; veterinary preparations for treating and preventing fleas on companion animals; veterinary preparations, namely, vaccines for companion animals
Owner
- Elanco US Inc., Indianapolis, IN, US
- Elanco US Inc., Greenfield, IN, US
Prosecution history
- 03 Oct 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Oct 2026 — SOU EXTENSION 5 GRANTED
- 26 Aug 2026 — SOU EXTENSION 5 FILED
- 03 Oct 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Aug 2026 — SOU TEAS EXTENSION RECEIVED
- 19 Jun 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 19 Jun 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Jun 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 Jun 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 19 Jun 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 19 Jun 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 16 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Dec 2025 — SOU EXTENSION 4 GRANTED
- 15 Dec 2025 — SOU EXTENSION 4 FILED
- 15 Dec 2025 — SOU TEAS EXTENSION RECEIVED